One of the largest IPOs in London this year is already facing pressure from short-sellers, less than a month after it made its debut on the London Stock Exchange.
Keep Reading →
July 26 - Hedge Funds, Insider Trading
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Keep Reading →
December 17 - ETF Trading, Hedge Funds, News, Tech
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher's favorite dividend ...
Keep Reading →
December 7 - Dividend Stocks, Hedge Funds, News
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Keep Reading →
February 5 - Hedge Funds, News
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital.
Keep Reading →
December 28 - Hedge Funds, News, Quantitative Investing
Analysts remain optimistic that Cambrex Corporation (NYSE:CBM) will enjoy revenue and earnings growth next year despite sales pressure on its leading product; Anthony Bozza of...
Keep Reading →
October 26 - Hedge Fund Investor Letters, Hedge Funds, News
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
Keep Reading →
July 6 - News
Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually in an attempt to stay healthy...
Keep Reading →
May 3 - Hedge Funds, News
What are the 11 Most Profitable Companies In The Fortune 500? Membership in the Fortune 500 is one of the most prestigious honors a company can have.
Keep Reading →
April 23 - Lists, News
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly much wealthier) shareholder...
Keep Reading →
April 4 - Lists, News
Dividends are an investor's best friend.
Keep Reading →
March 16 - Hedge Fund Analysis, News
2016 was not a very good year for biotech stocks to say the least.
Keep Reading →
March 10 - News, Stock Analysis
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.
Keep Reading →
March 8 - Hedge Funds, News
Public access for Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA will be provided in Ontario to adults who need the drug for the hepatitis C treatment.
Keep Reading →
February 23 - News, Stock Analysis
The 10 most generous companies in the US are familiar and well-known names.
Keep Reading →
February 3 - Dividend Stocks, Lists, News
There are almost too many speculations of changes to come in Washington, D.C.
Keep Reading →
January 23 - News, Stock Analysis
A federal judge in Pennsylvania has admonished the state for restricting inmates’ access to drugs and particularly those for hepatitis C.
Keep Reading →
January 5 - News, Stock Analysis
While most westerners don’t have to worry about hepatitis B virus (HBV) due to currently available and effective vaccines, HBV is still an incurable disease, with a staggering...
Keep Reading →
December 28 - News, Stock Analysis
Apple Inc. shares currently trade at a trailing price earnings ratio of 14.
Keep Reading →
December 24 - Hedge Fund Analysis, Hedge Funds, News
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
Keep Reading →
December 23 - News, Stock Analysis
Up to now, I have been very vocal with respect to my bullish opinion regarding Gilead Sciences, Inc.
Keep Reading →
December 22 - News, Stock Analysis
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.
Keep Reading →
December 21 - News, Stock Analysis
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Keep Reading →
December 21 - News, Stock Analysis
Here’s a breakdown on how the Magic Formula Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks and is 60% invested.
The return on the invested capital is 5.
Keep Reading →
December 9 - News, Stock Analysis
The election of Donald Trump has heralded an era of optimism in the healthcare industry, which has been one of the worst performing sectors over the past two years.
Keep Reading →
December 4 - Hedge Fund Analysis, Hedge Funds, News
Gilead Sciences, Inc. (NASDAQ:GILD) has switched course and has begun aggressive marketing of its HIV drug Truvada as a preventative medicine for HIV-negative healthy people.
Keep Reading →
December 1 - News, Stock Analysis
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
Keep Reading →
November 29 - News, Stock Analysis
In most cases a new method of drug delivery can occasionally alter markets a bit and cause some shifts. In rare cases though, it can fundamentally change an entire sector.
Keep Reading →
November 23 - News, Stock Analysis
GlobeImmune Inc (OTCMKTS:GBIM) shareholders did not have a good week last week.
Keep Reading →
November 21 - News, Stock Analysis
Today, I’m going to post some charts on a few trade setups that I’m focused on and which may provide a trade or two over the coming sessions.
Keep Reading →
November 15 - News, Stock Analysis
ValueWorks LLC is a New York-based, value-focused long/short equity hedge fund founded in 2001 by Charles Lemonides, a CFA who previously served as the Chief Investment Officer...
Keep Reading →
November 15 - Hedge Fund Analysis, Hedge Funds, News
Legendary investor Julian Robertson, founder of Tiger Management, sees tremendous upside in biotech stocks right now. The billionaire told CNBC in a recent interview that fears...
Keep Reading →
October 29 - ETF Trading, Hedge Fund Analysis, Hedge Funds, News, Tech
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September.
Keep Reading →
September 27 - Market Movers, News
After being range-bound for the last few weeks, crude promises to be a little bit more volatile in the near-term following today's release of the EIA inventory numbers and the...
Keep Reading →
September 21 - Market Movers, News
Equities have rebounded in trading today following the sell-off on Tuesday.
Keep Reading →
September 14 - News, Stock Analysis
The US stock market is mixed on Tuesday amid news in the M&A space and Institute for Supply Management's data that showed non-manufacturing index slump to 51.4, the lowest ...
Keep Reading →
September 6 - Market Movers, News
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
Keep Reading →
September 5 - Market Movers, News
Times are tough for healthcare stocks as investors keep a distance from the sector following drug-pricing control concerns and political clamor.
Keep Reading →
August 29 - Hedge Funds, News
Crude futures are again in the red as traders prepare for another API inventory release later today.
Keep Reading →
July 26 - Market Movers, News
The highly anticipated quarterly 13F filings for the second quarter of 2016 are slowing flowing in, enabling retail investors and analysts to examine the equity portfolios of ...
Keep Reading →
July 22 - Hedge Fund Analysis, Hedge Funds, News
For the section of our report detailing events in biotech this past couple of weeks, we’ve got two focus companies – one big, one small. They are Gilead Sciences, Inc.
Keep Reading →
July 7 - News, Stock Analysis
Healthcare stocks, along with food and drink-related securities, are usually recommended as defensive holdings for recessions and bear markets, as individuals have to eat, drink...
Keep Reading →
July 5 - Hedge Funds, News
Although there was a ton of cash on the sidelines ahead the United Kingdom’s referendum on whether to leave the European Union or not, most hedge fund managers appear to have...
Keep Reading →
June 30 - Hedge Fund Analysis, Hedge Funds, News
Market sentiment is positive on Thursday after polls suggesting low chances of a Brexit. A decline in U.S.
Keep Reading →
June 23 - Market Movers, News
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant for investing in companies...
Keep Reading →
May 16 - Hedge Funds, News
Nigel Greig and Kenneth Cowin’s Gabalex Capital recently submitted its 13F filing with the Securities and Exchange Commission for the reporting period ending March 31, revealing...
Keep Reading →
May 15 - Hedge Fund Analysis, Hedge Funds, News
Billionaire David Harding is a physicist by education, hence, it is no surprise that he trusts sophisticated computer models even when it comes to stock picking.
Keep Reading →
May 11 - Hedge Fund Analysis, Hedge Funds, News
At a time when crude futures have hit another monthly high and gold futures are strong, shares of Amazon.com, Inc.
Keep Reading →
April 29 - Market Movers, News
Although the biotechnology sector was the most profitable sector in 2015, biotech stocks suffered the same fate as most others during the first quarter, having been hit by a ...
Keep Reading →
April 5 - Hedge Fund Analysis, Hedge Funds, News
Since the beginning of 2016, the healthcare sector has been one of the worst performing and is down by almost 8.80% year-to-date, outperforming only the financial sector that ...
Keep Reading →
March 1 - Hedge Funds, News
